New technology powered by artificial intelligence (AI) could offer greater communications customizability for people with conditions such as amyotrophic lateral sclerosis (ALS). In an October press release, the Scott-Morgan Foundation and Lenovo introduced “a new technology suite combining predictive AI, hyper-realistic avatars, personalized voices, and eye-gaze tracking.” The introduction came at Lenovo Tech World 2024,…
Scott-Morgan Foundation, Lenovo Introduce AI-Powered Communication Tech for People with ALS
Briefly: Workshop to Investigate GLP-1R and Nervous System Disorders; ALS Survey Investigates AI Impact on AAC
Featuring the National Academies of Sciences, Engineering, and Medicine; and Boston Children’s Hospital.
NASEM Public Workshop to Discuss Applications of GLP-1R Agonists The National Academies of Sciences, Engineering, and Medicine (NASEM) is hosting a Sept. 10 day-long workshop to discuss the impact of glucagon-like peptide-r receptor (GLP-1R) agonists on central nervous system disorders, including neurodegenerative diseases such as Parkinson’s. The workshop will bring together experts from a number…
Briefly: Paralympians in Paris; AI Robot on Sidewalk Patrol
Featuring the 2024 Paralympic Games and Daxbot.
2024 Paralympics Get Underway The summer Paralympic Games are underway in Paris, where hundreds of elite athletes with disabilities will compete in 22 sports. Access Mobility Management’s Paralympics primer for information on how to view the Games and when your favorite sports will be contested. Competition continues through Sept. 8. Dax the Robot Looks for…
MS Patients: ChatGPT Responses Are More Empathetic Than Those from Neurologists
A new study examined how patients reacted to information provided by artificial intelligence.
A new study published in the Journal of Neurology said patients with multiple sclerosis (MS) rated responses produced by artificial intelligence (AI) — specifically, ChatGPT — to be more empathetic than responses from neurologists. The April 3 study was titled, “ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses…
FDA Clears AI-Powered Brain MRI Software
Pixyl.Neuro has been used to detect and follow the progression of multiple sclerosis.
The U.S. Food & Drug Administration (FDA) has given 510(k) clearance to Pixyl.Neuro, brain MRI analysis software that’s powered by artificial intelligence (AI). In a Nov. 20 news announcement, Pixyl, a French medtech company specializing in AI-powered MRI solutions to improve patient care, said Pixyl.Neuro “automatically analyzes brain MRI images to support rapid detection, early…